About our bioanalytical and analytical laboratories

Initially located at the Laboratory of Molecular Endocrinology at the CHUL Research Center in Quebec City, the analytical laboratory has been relocated and has expanded its equipment and operations at the Quebec Technology Park, also in Quebec City.

EndoCeuticsTM’ bioanalytical and analytical laboratories offer high-throughput, high quality analytical and bio-analytical services to the biopharmaceutical industry, biotechnology industry, research organizations as well as academic and government institutions. All operations are GLP compliant. 

During the past three decades, Dr. Fernand Labrie, founder and CEO of EndoceuticsTM and his team have developed treatments against cancers sensitive to sex steroids, especially prostate and breast cancer. In the recent past, EndoceuticsTM has been pursuing the development of novel treatments using a non-estrogenic approach, namely prasterone or dehydroepiandrosterone (DHEA), an exogenous sex steroid precursor against vulvovaginal atrophy, sexual dysfunction and other problems of menopause, including osteoporosis.

Such research needs the most advanced technology to identify and measure steroids and other small molecular weight compounds and metabolites. This technology is based upon mass spectrometry which replaced the immunoassay-based techniques. 

See www.fernandlabrie.com/publications/ and select GC-MS/MS and LC-MS/MS Steroid Assays for a list of publications describing data obtained using mass spectrometry based steroid assays.